Skip to content

Gight Pilot Study

Pilot Study on Falls Prevention with GIGHT, The Guiding Light.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21036
Enrollment
150
Registered
2018-04-07
Start date
2017-10-05
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Falling, fall risk

Interventions

Gight™ (The guiding light) is an innovative lighting device, consisting of series of low voltage (12V) LED’s, which are connected in linear strips that can be placed at the floor, connected to the sid

Sponsors

Gight-BV, BrabantZorg Oss
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Participant is at least 65 years of age - Participant is able to get up from bed and walk to the bathroom independently - Participant is able to collaborate in outcome registration by themselves or assisted by a caregiver and/or partner - Participant gives informed consent for participating in the study

Exclusion criteria

Exclusion criteria: Presence of cognitive, hearing or vision impairments which make it impossible to take part in the pilot study as judged by the BrabantZorg professionals and the caregivers

Design outcomes

Primary

MeasureTime frame
Fear of falling when leaving the bed in darkness on a scale from 0-10. This item is adapted from the well validated FES-I (Falls Efficacy Scale), which has no item on fear of falling over night. Difference post-intervention (at 1-6 months after start) and baseline is the primary outcome.

Secondary

MeasureTime frame
1. Fall rate (as reported by participants on a falls calendar) 2. Sleep quality over the last month on a scale form 0-10 (measured with an item from the well validated Pittsburgh Sleep Quality Inventory (PSQI)) 3. Gight acceptability and subjective fear of falling and sleep quality (as reported in a semi-structured interview about the experience of Gight usage) Difference post-intervention (at 1-6 months after start) and baseline are also taken for secondary outcomes.

Contacts

Public ContactThessa Thölking
thessa.tholking@radboudumc.nl+31 643847166

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)